Aduro Prepares $80M IPO After Inking Novartis Partnership

Venture capital-backed Aduro Biotech Inc. fine-tuned plans Monday to raise up to $80 million in its initial public offering, sailing forward with its public debut plans a week after the immuno-oncology...

Already a subscriber? Click here to view full article